medigraphic.com
ISSN 1561-2937 (Print)

2016, Number 3

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2016; 22 (3)

Estimation of Global Risk Cardiovascular in the Colon Municipality. Matanzas, Cuba

Armas RNB, Dueñas HA, Suárez MR, Llerena RL, de la Noval GR, Varona PP, Nordet CP

Language: Spanish
References: 28
Page:
PDF size: 330.73 Kb.


ABSTRACT

Introduction: Cardiovascular diseases continue to be the leading cause of death in Cuba, to predict the likelihood of suffering from them, different tables have been proposed, including those of Gaziano.
Objective: To determine the levels of global cardiovascular risk in the population of the municipality Colón, Matanzas, year 1999.
Method: Cross-sectional descriptive study. Universe: 21 462 individuals between 35 and 74 years of age randomly selected in the study "Tobacco or Health". Sample: 18 159 people. Variables: age, sex, systolic blood pressure, smoking, obesity, diabetes mellitus and cardiovascular disease. Individuals were classified into Global Cardiovascular Risk according to original and modified Gazian risk charts. Percentages and 95% CI were calculated; To evaluate the relationship between qualitative variables, independence test and significance level of 95% were used.
Results: Predominated age group of 35-44 followed by 45-64 age group, females were more represented than males 26.5% of individuals classified at "very low" risk; 12.2% in "high" risk and 5% in "very high risk". The 17.9% classified in high risk level: in men 25.4% and in women 12.0%. The increase in risk was proportional to age.
Conclusions: The male sex and the increase of the age are factors that influence the increase of Global Cardiovascular Risk. The levels of moderate and high risk determined by Gaziano tables in this population were higher than in other studies using other tables, which could underestimate the categories of greater risk in Cuba.


REFERENCES

  1. Laslett L J., Alagona P, Clark B A., Drozda J P., Saldivar F, Wilson S R., Poe C, Hart M. The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues. A Report From the American College of Cardiology. J Am CollCardiol 2012;60(S):1–49

  2. Mendis S, Puska P, Norrving B. Global Atlas on Cardiovascular Disease Prevention and Control. World Health Organization (in collaboration with the World Heart Federation and World Stroke Organization. 2011. Disponible en: http://www.who.int/cardiovascular_diseases. [Consultado 15 de julio de 2016].

  3. World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. Aug 24, 2007. Disponible en: http://www.who.int/cardiovascular_diseases/guideline s/Full%20text.pdf [Consultado 15 de julio de 2016].

  4. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.

  5. World Health Organization. Global Health Observatory Data Repository. Mortality: Cardiovascular diseases and diabetes, deaths per 100,000 [Internet]. Geneva: World Health Organization; 2008 [cited 2013 Jan 11]; [about 1screen]. Available from: http://apps.who.int/gho/data/?vid=2490#

  6. MINSAP. Anuario Estadístico de Salud Pública de Cuba. 2015. Disponible en: http://www.sld.cu/galerias/pdf/sitios/dne/anuario_201 5_5e.pdf [Consultado 15 de julio de 2016].

  7. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 . European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37:2315-81

  8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Educa-tion Program (NCEP) Expert Panel on Detection, OMS.

  9. Prevención de las enfermedades cardiovasculares. Guía de bolsillo para la estimación y el manejo del riesgo cardiovascular. Ginebra 2008. ISBN-978-924 3547282.

  10. Fuster V. ACC scientifi c statement: Assessment of cardiovascular risk by use of multiple risk factor assessment equations: a statement for health care professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999 Sep 28;100(13):1481–92.

  11. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998 May 12;97(18):1837–47.

  12. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation. 2002 Jan 22;105(3):310–5.

  13. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. The SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003 Jun;24(11):987–1003.

  14. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. British Hypertension Society guidelines for hypertension management 2004 (BHSIV): summary. BMJ. 2004 Mar 13;328(7440):634–40.

  15. Jackson R. Updated New Zealand cardiovascular riskbenefi t prediction guide. BMJ. 2000 Mar 11;320(7236):709–10.

  16. Álvarez A. Las tablas de riesgo cardiovascular: Una revisión crítica. Medifam, 2001;11:122-39.

  17. Nordet P, Mendis S, Dueñas A, de la Noval R, Armas N. de la Noval I, et al. Total Cardiovascular Risk Assessment and Management Using Two Prediction Tools, with and without Blood Cholesterol. MEDICC Review. 2013;15:36-40.

  18. De la Noval R, Armas NB, de la Noval I, Fernández Y, Pupo HB, Dueñas A, et al. Estimación del Riesgo Cardiovascular Global en una población del Área de Salud Mártires del Corynthia. La Habana, Cuba. Rev Cubana CardiolCirCardiovasc. 2011;17:62-8.

  19. Armas NB, de la Noval R, Dueñas A, Castillo JC, Suárez R, Castillo A. Estimación del riesgo cardiovascular mediante tablas de la Organización Mundial de la Salud. Área de salud “Héroes del Moncada”. Rev Cubana CardiolCirCardiovasc 2014; 20(1).

  20. Varona Pérez P; Armas Rojas N B; Medina Ramón S; Dr. Bonet Gorbea M, Dueñas Herrera A; Estimación del riesgo cardiovascular en la población cubana. Una aproximación al tema. Revista Cubana de Cardiología y Cirugía Cardiovascular. 2015;21(4). ISSN: 1561- 2937.

  21. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus nonlaboratorybased method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet. 2008 Mar 15;371(9616):923–31.

  22. Mendis S, Mohan V. Non-laboratory-based prediction of cardiovascular risk. Lancet. 2008;371:878-9.

  23. Estudio Tabaco o Salud. Informe Técnico. Instituto de Cardiología y Cirugía Cardiovascular. La Habana. Cuba. 2015.

  24. WMA. Declaración de Helsinki de la Asociación Médica Mundial. Principios éticos para las investigaciones médicas en seres humanos. 59ª Asamblea General; 2008 octubre; Seúl, Corea. [citado 1 de Diciembre de 2016]:5. Disponible en: http://www.wma.net/es/30publications/10policies/b3/1 7c_es.pdf

  25. Castillo Sánchez G A., Dueñas Herrera AF, Armas Rojas N B., de la Noval García R., Suárez Medina R. Riesgo cardiovascular global según tablas de Gaziano en el municipio de Jagüey Grande Matanzas Cuba. 1999-2008. Tesis para optar por el Título de Especialista de 1er grado en Cardiología. Instituto de Cardiología y Cirugía Cardiovascular. 2014:25-37

  26. Marma AK, Berry JD, Ning H, Persell SD, Lloyd- Jones DM. Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006. 2010;3(1):8-14.

  27. Dugee O, Oum S, Buckley BS, Bonita R. Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in Asia. BMC Public Health. 2013;13(1):539.

  28. De la Noval R, Romero SE, Dueñas AF, Armas NB, Acosta M, Ortega Y. Estimación del Riesgo Cardiovascular Global en trabajadores del Instituto de Cardiología y Cirugía Cardiovascular. Rev Cubana CardiolCirCardiovasc. 2013;19:65-70.




2020     |     www.medigraphic.com